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Objective: Wound infection remains a major source of postoperative morbidity leading to prolonged
hospital stays and increased total cost, including indirect expenses related to the wound infection. We
examined whether there is any higher risk of wound infection in patients undergo a reoperation after an
initial operation or excision/incision biopsy.
Methods and Results: A retrospective review of medical charts of patients with breast operations between
January 1990 and July 2008 was carried out. The overall incidence of wound infection was 18.2% (231/
1267). The rate of wound infection was (32%) when reoperation was done after previous modiﬁed radical
mastectomy, 18.9% and 16.8% when the previous operations were lumpectomy/segmenectomy with
axillary dissection and simple mastectomy without axillary dissection, respectively and (10.8%) when
reoperation was performed after previous biopsy. Reoperation involving axillary dissection was associ-
ated with signiﬁcantly higher rates of wound infection (p< 0.01). Antibiotic prophylaxis continued into
the postoperative period was associated with signiﬁcantly decreased rate of wound infection (p< 0.01).
Conclusions: Initial procedure affects the risk of wound infection in subsequent operation in patients with
breast cancer. Signiﬁcantly higher risks of wound infection are seen in those patients who had under-
gone axillary dissection or modiﬁed radical mastectomy.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Wound infection remains a major source of postoperative
morbidity leading to prolonged hospital stays and increased total
cost, including indirect expenses related to the wound infection.1
Advances in surgical practice and antibiotic prophylaxis have not
been successful in preventing the occurrence of wound infection
although signiﬁcant decreases in incidence have been reported. The
average cost of a surgical wound infection has proven difﬁcult to
estimate and varies depending on the type of surgical procedure.2
The entire economic burden of wound infections is rarely taken
into account, as the majority of wound infections are not diagnosed
until after hospital discharge3,4; the cost to the patient in
prescription charges, visits to the hospital, loss of earnings, and
reduced quality of life are largely underestimated.2,5,15 In India,
breast cancer is estimated to develop in approximately 230,000
women per year.6 Keeping in view the recent trends, more womenartments, 28, Charu Avenue,
ahoo.co.in (M. Ashraf).
ciates Ltd. Published by Elsevier Ltare opting for breast conservation therapy over mastectomy7; thus
with many women requiring one or more reexcisions to achieve
negative margins. As the incidence of local recurrence has been
shown to be increased with a concomitant decrease in overall
survival when adjuvant therapy is delayed for more than 30 days;
and wound infections after surgical therapy will delay adjuvant
therapy, so prevention of postoperative wound infections takes on
added importance.7
Because breast surgery has been described as a clean operation,
low wound infection rates have been reported, especially in pop-
ulations treated with conservative techniques.8,9 The overall
surgical site infection (SSI) rate following mastectomy reported to
the Centers for Disease Control and Prevention National Nosoco-
mial Infections Surveillance System from 1992 to 2004 was 1.98%.10
Wound infection rates have been reported to be the lowest
following breast-conserving surgery, ranging from 1.5% to
10.8%.9–12 Factors such as age, obesity, biopsy technique, neo-
adjuvant therapy, preoperative hospital stay, longer duration of
operation, the use of drains, and breast reconstruction have all been
suggested to explain the higher incidence of wound Infection after
operation for breast cancer.5,7,13,14,18–20d. All rights reserved.
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This studywas conducted in the department of surgical oncology
at Chittaranjan National Cancer Institute, Kolkata, India. After
obtaining institutional review board approval, a retrospective
review of medical charts of patients with breast operations between
January 1990 and July 2008 was carried out. Only patients who had
undergone more than one operation on breast were included in the
study. Data were collected on patient demographics, the number of
reoperations undergone by each patient, types of procedure, pres-
ence of co morbidities such as diabetes or immunosuppression, and
antibiotics used for prophylaxis. The details of preoperative
chemotherapy and/or radiotherapy were recorded for every patient.
Breast procedures included open biopsy (incisional or excisional),
segmental mastectomy (lumpectomy), or mastectomy (total or
modiﬁed radical) with or without immediate reconstruction.
Wound infection was deﬁned by means of Centers for Disease
Control and Prevention 1999 guidelines [Infection occurs within 30
days after the operation if no implant is left in place or within 1 year
if implant is in place and the infection appears to be related to the
operation and infection involves deep soft tissues (e.g., fascial and
muscle layers) of the incision]. The deﬁnitions entails at least one of
the following criteria: (1) purulent drainage; (2) positive aseptically
obtained culture; (3) periincisional erythema and incision opened
by the surgeon; and (4) physician diagnosis of infection, which was
predominantly a diagnosis of cellulitis for which antibiotics were
prescribed. Dates of SSI were collected, with rates calculated for
both a 30-day postoperative period and beyond. Findings of wound
culture, if available, were recorded.v2 or Fisher’s exact test was used
to compare SSI rates for patients who did and did not receive
postoperative antibiotic prophylaxis. Logistic regressionwas used to
assess the effect of postoperative antibiotic prophylaxis while
adjusting for potential confounding variables.3. Results
Overall 1267 cases had undergonemore than one operation. 882
(69%) of them had duct cell carcinoma not otherwise speciﬁed type,
37 (3%) had medullary type, 55 (4%) had colloid type and 5 (0.4%)
had carcinosarcoma. DCIS was present in 200 (15.7%) and lobular
carcinoma was in 88 (15.7%) Table 1. Patients ranged in age from 15
to 79 years. The number of operations ranged from 2 to 6. Primary
(ﬁrst) operation was excisional/incisional biopsy in 111 (8.76%),
lumpectomy/segmental mastectomy with or without axillary
dissection in 894 (70.5%), total mastectomy in 225 (17.75%), and
modiﬁed radical mastectomy in 37 (2.9%) patients. The average
interval between initial intervention and the reoperation was 28.3
days (median of 10.2 days, range 5–425 days). The reoperative
procedures were delayed in patients who had received chemo-
therapy or had presented with a locoregional recurrence after
completion of surgical and adjuvant therapy. Types of reoperation
undergone by the patients included mastectomy with or without
axillary dissection, lumpectomy/segmental mastectomy with orTable 1
Distribution of patients according to diagnosis.
S. no Histological type Number Percentage
1 Duct cell cancer NOS 882 69%
2 Medullary cancer 37 3%
3 Colloid cancer 55 4%
4 Lobular carcinoma 88 6.9%
5 DCIS 200 15.7%
6 Carcinosarcoma; two 5 0.4%
Total 1267 100%without axillary dissection and mastectomy with reconstruction.
Mastectomy was by far the commonest reoperation comprising
78.3% of procedures including cases with reconstruction (Table 2).
Wound infection had occurred on 3–47 days after surgery (mean
10.5days). The patients were discharged on ﬁfth to sixth post-
operative day. None of the patients had required readmission to the
hospital and were managed on outpatient basis. The overall inci-
dence of wound infection was 18.2% (231/1267). The rate of wound
infection was (32%) when previous operation was modiﬁed radical
mastectomy, 18.9% and 16.8% when the previous operations were
lumpectomy/segmenectomy with axillary dissection and simple
mastectomy without axillary dissection, respectively and (10.8%)
when reoperation was performed after previous biopsy. Reopera-
tion involving axillary dissection was associated with higher rates
of wound infection (Table 2). When test of proportion was applied,
the results were statistically signiﬁcant (p< 0.05) in favour of
modiﬁed radical mastectomy and lumpectomy/segmentectomy
with axillary dissection in comparisonwith the initial operations of
biopsy and simple mastectomy (Table 2). 61 patients had diabetes
mellitus; 34 (55.7%) developed wound infection.31 patients were
on thyroxine replacement therapy for hypothyroidism; 1 (3%)
patient developed wound infection. Other associated comorbidities
like chronic obstructive pulmonary disease, mitral insufﬁciency,
atrial ﬁbrillation was present in 124 patients and 7 (5.6%) had
wound infection. 989 (78%)patients had received both preoperative
(single dose) and postoperative (mean 2.9, range 1–6 doses) anti-
biotic prophylaxis and 228 (23%) developed wound infection as
compared with 278 (21.9%)patients who had received only post
operative antibiotic prophylaxis (mean 4.57, range 4–6 doses) and
wound infection developed in 103 (37%). Preoperative antibiotic
prophylaxis continued into the postoperative period was associated
with signiﬁcantly decreased rate of wound infection (p< 0.01)
Table 3. However, it’s hard to conclude whether the decreased rate
of wound infection was affected in any measure by the post oper-
ative antibiotic usage or it was primarily the result of preoperative
dose of antibiotics. 193 patients had positive wound cultures.
Pseudomonas aeruginosa and staphylococcus were the commonest
microorganisms, cultured in 26.4% and 24.3% cases, respectively.
Staphylococcus epidermis and serratia sp. were documented in 16%
cases each. MRSA were reported in 13.5%cases whereas the strep-
tococcus was found in the least number of cases (3.6%) [Table 4].
575 patients (45.3%) had received chemotherapy average 21.6 days
(range 18–78 days) before reoperation. 265 (20.9%) patients had
completed chemotherapy and radiation treatment, with 215 (81%,
n¼ 265) having completed the adjuvant treatment more than 6
months before reoperation and 45 (16.9% n¼ 265) having
completed second line chemotherapy average 2.7 months before
reoperative procedure. Drain placement was done in all patients.
Drain removal was done on an average sixth day (range 4–11 days).
4. Discussion
The overall incidence ofwound infection following reoperation in
breast cancer was 18.2% in our study, which is signiﬁcantly higher
than the 1–3% infection rate expected for a ‘clean’ operation. The
increased incidence of wound infection subsequent operations
mirrors the infection rates following open biopsy, segmental
mastectomy, and mastectomy. Tran CL et al.12 have also reported
a higher incidence of wound infection after reoperative breast
surgery albeit lower (6.1%)than that of our study. However, they12
have included a large number of cases who had undergone only core
biopsy before themain operation.We did not include cases who had
undergone core biopsy as an initial procedure because, as has been
reported in the literature, core biopsy is associated with extremely
low risk of wound infection in subsequent operations.12,19,20,23
Table 2
Procedure-wise incidence of wound infection (Number of procedures, n¼ 1267).a
S. no Reoperation Primary (previous) operation
Procedure Wound infection Procedure Wound
infection
Procedure Wound
infection
Procedure Wound
infection
Procedure No. of
cases
Biopsy No. of cases % SM No of
cases
% L/SþAD No of
cases
% MRM n %
1 SMAD 312 23 3 13 70 11 15.7 219 39 17.8 – – ¼
2 TM 200 35 3 8.5 – – – 165 27 16.3 – – –
3 L/S þAD 205 28 3 10.7 – – – 177 34 19 – – –
AD 70 10 1 10 – – – 60 12 20 – – –
4 MRM 415 15 2 13 133 24 18 267 56 20.9 – – –
5 Mþ R 65 – – – 22 3 13 6 1 16.7 37 12 32
6 Total 1267 111 12 10.8 225 38 16.8 894 169 18.9 37 12 32
Total no. of wound infections: 231((18.2%; n¼ 1267)
a Abbreviations: SMAD: Simple mastectomy with axillary dissection; TM: Total mastectomy; L/SþAD: Lumpectomy/segmentectomy with axillary dissection; MRM:
Modiﬁed radical mastectomy; þAD: With axillary dissection; AD: Without axillary dissection; Mþ R: Mastectomy with reconstruction.
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as an independent risk factor for subsequent wound infection.21
Some prior studies have considered the relationship between biopsy
type and infection and Fine needle aspiration followed by mastec-
tomy had the least risk of wound infection compared to two-step
operations (i.e., biopsy with delayed mastectomy).18,19,22 In addition,
Rotstein et al.19 noted that mastectomy had a higher incidence of
wound infection when preceded by segmental mastectomy as
opposed to excisional biopsy. Likewise, Lipshy et al.20found that
mastectomies had lower infection rates when preceded by less
invasive biopsy techniques, leading them to recommend ﬁne needle
aspiration or core biopsy. Tran Cl et al. 12 have also documented
a higher post-operative wound infection rate after initial invasive
procedures. The results of these studies are consistent with our
ﬁnding that more invasive biopsy techniques and operative proce-
dures resulted in a higher incidence of wound infection at
reoperation.
When the initial operation performed was modiﬁed radical
mastectomy, the infection rate in subsequent reoperation was
double the overall wound infection rate. When lumpectomy/seg-
mentectomywith anaxillary dissection, either lymphnode sampling
or complete lymph node clearance, was performed in the initial
procedure, the incidence of wound infection was not only higher
than that of the overall wound infection rate but it was signiﬁcantly
higher than the incidence in reoperation cases which had not
undergoneaxillary dissectionduring initial operation (p< 0.05). This
ﬁnding may be secondary to increased bacterial cross-contamina-
tion from the axilla,which is known to beheavily colonizedwith skin
ﬂora, and may also be a result of alterations in lymphatic ﬂow
following disruption of lymphatic channels in the axilla.7,17
Many studies have been reported that have assessed the efﬁcacy
of prophylactic antibiotics in operations for breast cancer.Ng D
et al.25 found in a nationwide survey, that, although antibiotic
prophylaxis is not explicitly indicated for breast surgery, its use for
these clean procedures is widely adopted, albeit to a differentTable 3
Inﬂuence of antibiotic regimens on wound infection.
S. No Antibiotic prophylaxis No. of
patients
Wound
infection
Percentage p-value*
1 Pre and postoperative
regimen
989 228 23% <0.01
2 Post operative
regimen
278 103 37%
Total 1267 231 18.2%
* Test of proportion was used for statistical calculation.extent in different countries, often on the personal decision of the
individual surgeon, but, currently, there is still no consensus
regarding their use.7,18,24 Platt et al.16 found an approximately 40
per cent relative reduction in the incidence of wound infection after
breast operation with the use of prophylactic antibiotics. Similarly,
Esposito et al.24 reported that antibiotic usage is more effective
than placebo in preventing postoperative infections in breast
surgery. Despite the lack of clear cut recommendations, prophy-
lactic antibiotics are used routinely for many breast operations.
Many surgeons will use prophylactic antibiotics for breast reoper-
ations whether they do so or not for the initial breast operations.
The rationale is that both the incision and wound cavity are seeded
with skin bacteria by the ﬁrst operation, and reoperation further
increases the bacterial load, thereby increasing the risk of wound
infection. Moreover, the serous ﬂuid that forms in thewound cavity
after initial operation can provide a nutrient-rich medium for
bacterial proliferation.12
We observed a statistically signiﬁcant decrease in the post-
operative wound infection rate [p< 0.01] in patients who had
received antibiotics. Although the patients in our study had
received pre- as well as postoperative antibiotics, we believe that
preoperative dose of antibiotics has been, if at all, a decisive factor
in causing a reduction of wound infection rate. The patients who
received only post-operative antibiotic prophylaxis, on the
contrary, had a signiﬁcantly higher rate of wound infection.
Throckmorton AD et al.26 also, have reported in their randomized
controlled study that post-operative antibiotic prophylaxis did not
effect a reduction in the rate of wound infection. P. aeruginosa and
Staphylococcus aureus were the commonest organisms causing
wound infection in our study although serratia sp. And staphylo-
coccus were also signiﬁcantly important organisms albeit less
common.MRSAwere reported in only 13.5% cases only butmajority
of these were reported in patients who had undergone reoperation
after the year 1999. We did not study the relationship of wound
infectionwith preoperative chemotherapy or radiotherapy becauseTable 4
Proﬁle of microorganisms causing wound infection (n¼ 193).
S. No. Type of organism cultured No. of cases Percentage
1. Pseudomonas aeruginosa 51 26.4%
2. Staphylococcus aureus 47 24.3%
3. MRSAa 26 13.5%
4. Staphylococcus epidermis 31 16.0%
5. Serratia sp. 31 16.0%
6. Streptococcus 7 3.6%
Total 193 100%
a MRSA-Methicillin resistant staphylococcus aureus.
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which have documented that chemotherapy and radiation do not
lead to any increase in post operative wound infection.27,28
However, on the basis of this nonrandomized retrospective study of
ours, it is hard to make deﬁnitive conclusions regarding the
combined effect of reoperation and use of prophylactic antibiotics
on the incidence of postoperative wound infections. However,
based on our data, it appears that patients undergoing reoperative
surgical procedures after previous incision/excision biopsy or
mastectomy especially involving axillary dissection are a relatively
high-risk group that may be more likely to beneﬁt frommethods to
reduce the risk of developing postoperative wound infection.5. Conclusions
The risk of wound infection in breast cancer is increased with
reoperation.
This increase is most apparent when the initial procedure is
a modiﬁed radical mastectomy or segmental mastectomy
combined with lymph node dissection. Although risk of wound
infection is lesser when initial procedures are incision/excision
biopsy or mastectomy without axillary dissection, but it is still
substantially higher than initial core biopsy or ﬁne needle aspira-
tion cytology followed by deﬁnitive operation. Although the use of
prophylactic antibiotics for primary operation is still controversial,
it seems to decrease the wound infection risk when used for
reoperation. A prospective randomized, controlled trial comparing
antibiotic versus placebo in patients undergoing reoperative breast
surgery would be warranted to fully settle this question.
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